Stock 300318 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Equities

300318

CNE000001QR4

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 15/05/2024 BST 		5-day change 1st Jan Change
5.36 CNY -1.29% Intraday chart for Beijing Bohui Innovation Biotechnology Group Co., Ltd. -5.30% -14.10%
04-26 Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Beijing Bohui Innovation Biotechnology Group Co Ltd, formerly Beijing Bohui Innovation Biotechnology Co Ltd, is a China-based company mainly engaged in inspection and testing business and blood products business. The Company operates two major reporting segments. The Inspection and Testing segment is mainly engaged in the research and development, production and sales of inspection instruments and inspection reagents. The Company's products for medical institutions mainly involve in vitro diagnostic testing, including human trace element testing and human papillomavirus (HPV) testing. The Company's testing equipment for non-medical institutions is mainly small mass spectrometers and related products. The Biological Products segment is mainly blood products, which can be divided into products such as albumin, immunoglobulin, coagulation factors and vaccines. The Company distributes its products within the domestic market and to overseas market.

Number of employees: 1,773

Sales per Business

CNY in Million2022Weight2023Weight Delta
Biological Products
70.1 %
509 64.0 % 733 70.1 % +43.90%
Inspection and Testing
29.9 %
287 36.0 % 313 29.9 % +9.04%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
91.2 %
689 86.5 % 953 91.2 % +38.42%
Abroad
8.8 %
107 13.5 % 92 8.8 % -14.01%

Managers

Managers TitleAgeSince
Yan Jiang CEO
 Chief Executive Officer 54 16/03/20
Hai Feng Dong DFI
 Director of Finance/CFO 40 28/06/20
Jiang Hong Du CHM
 Chairman 56 25/06/01
Wei Wang BRD
 Director/Board Member 46 16/03/20
Shu Hui Niu PRN
 Corporate Officer/Principal 51 -

Members of the board

Members of the board TitleAgeSince
Jiang Hong Du CHM
 Chairman 56 25/06/01
Jun Ban BRD
 Director/Board Member 57 28/06/20
Zhi Wei Shen CHM
 Chairman 46 31/05/22
Yan Jiang CEO
 Chief Executive Officer 54 16/03/20
Li Zhao BRD
 Director/Board Member 67 15/05/17
Wei Wang BRD
 Director/Board Member 46 16/03/20
Xiaosu Zhang BRD
 Director/Board Member 64 28/06/20
Chen Yang BRD
 Director/Board Member 41 28/06/20
Lan Lan Hu BRD
 Director/Board Member 38 28/06/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 816,900,495 308,639,286 ( 37.78 %) 0 37.78 %

Shareholders

NameEquities%Valuation
Fullgoal Fund Management Co., Ltd.
1.223 %
9,015,866 1.223 % 6 M ¥
China Asset Management Co., Ltd.
0.0766 %
564,600 0.0766 % 406 207 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.005548 %
40,900 0.005548 % 29 426 ¥
Truvalue Asset Management Co. Ltd.
0.003608 %
26,600 0.003608 % 19 138 ¥
GF Fund Management Co., Ltd.
0.001316 %
9,700 0.001316 % 6 979 ¥
Shu Hui Niu
0.000039 %
288 0.000039 % 207 ¥
NameEquities%Valuation
Shu Hui Niu
0.6750 %
537,862 0.6750 % 386 970 ¥

Company contact information

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

No. 9 Life Garden Road Changping District

102206, Beijing

+86 10 88850168

http://www.bohui-tech.com
address Beijing Bohui Innovation Biotechnology Group Co., Ltd.(300318)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. Stock Beijing Bohui Innovation Biotechnology Group Co., Ltd.
-14.10% 607M
CSL LIMITED Stock CSL Limited
-2.32% 92.59B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.16% 41.43B
BIOGEN INC. Stock Biogen Inc.
-12.43% 33.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-20.82% 14.62B
INCYTE CORPORATION Stock Incyte Corporation
-9.66% 12.77B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.25% 11.58B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.00% 11.35B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.64% 8.97B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 8.3B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300318 Stock
  4. Company Beijing Bohui Innovation Biotechnology Group Co., Ltd.